Identification of transferrin and inhibin-like proteins in matrigel.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

1. The Synthetic Extracellular Matrix as a Maestro of the In Vitro Stem Cell Niche: Orchestrating Fate and Function.Biomedicines · 2026
   Review
2. Synthetic alternatives to Matrigel.Nature reviews. Materials · 2020
   Article
3. Proteome array identification of bioactive soluble proteins/peptides in Matrigel: relevance to stem cell responses.Cytotechnology · 2015
   Article
4. Characterization of immortalized rabbit lacrimal gland epithelial cells.In vitro cellular & developmental biology. Animal · 1999
   Article
5. Liver cell models in in vitro toxicology.Environmental health perspectives · 1998
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors at 3 institutions in 1 country.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as